Holen Sie sich die Stockscreener-App
10.31
1.62%
-0.17
Finanzdaten der Design Therapeutics Inc-Aktie (DSGN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Operating Expenses |
12.54%
22.18
|
19.71 | 18.17 | 19.31 | 21.57 |
| Operating Income/Loss |
12.54%
-22.18
|
-19.71 | -18.17 | -19.31 | -21.57 |
| Net Income/Loss |
14.34%
-20.16
|
-17.64 | -16.00 | -17.00 | -19.08 |
| Basic Average Shares |
1.74%
62.51
|
61.43 | 0.4734 | 56.95 | 56.86 |
| Diluted Average Shares |
1.74%
62.51
|
61.43 | 0.4734 | 56.95 | 56.86 |
| Basic Earnings Per Share |
10.34%
-0.32
|
-0.29 | -0.27 | -0.30 | -0.34 |
| Diluted Earnings Per Share |
10.34%
-0.32
|
-0.29 | -0.27 | -0.30 | -0.34 |
5.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):